Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Number of Sputnik V vaccines bought from Russia 2021, by country

Russia sold 100 million doses of the coronavirus (COVID-19) vaccine Sputnik V to India, which was also among the countries that produced it on its territory. In total, four Indian companies planned to produce 852 million doses of Sputnik V in 2021. Furthermore, Mexico was to import 7.4 million doses between February and April 2021, with more doses to be delivered in May. Sputnik V was authorized in 60 countries worldwide as of April 13, 2021. Russia applied for the vaccine approval in the European Union in January, while several EU countries approved its use earlier, such as Hungary or Slovakia.

Russia's first vaccine against COVID-19

In August 2020, Russia registered Sputnik V, the world’s first approved vaccine against COVID-19, which was developed at Gamaleya Research Institute in Moscow. After the third phase of clinical trials, the vaccine's effectiveness was measured at 91.6 percent. The mass vaccination in Russia started in January 2021. In December 2020, 30 percent of Russians would get vaccinated against COVID-19 with Sputnik V.

Will Sputnik V be available abroad?

In total, over 50 countries worldwide placed orders for Sputnik V from Russia. As of January 2021, The vaccine was used for vaccination in Russia, Belarus, Serbia. In October 2020, Russia applied for prequalification of Sputnik V at the WHO to speed up its availability worldwide. Other countries that would produce the vaccine, such as Brazil, China, India, or the Republic of Korea, would also sell it abroad. Among several countries surveyed in November 2020, the highest level of awareness about Sputnik V was recorded in Mexico.

Number of doses of the COVID-19 vaccine Sputnik V ordered from Russia or agreed to be produced abroad as of April 13, 2021, by country

You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

April 2021

Region

Russia

Survey time period

As of April 13, 2021

Supplementary notes

* In Algeria, the number of doses to be supplied in January 2021. In Brazil, the planned production is per month in the first half of 2021. In Mexico, the number of doses ordered from February to April 2021. In Serbia, the production volume planned as of March 14, 2021.
** Plans to produce Sputnik V on its territory.
*** In China, 60 million by Shenzhen Yuanxing Gene-tech, 100 million per year by TopRidge Pharma. In India, over 100 million doses per year by Hetero, up to 200 million per year by Virchow Biotech, 200 million by Stelis Biopharma, 252 million by Gland Pharma, and 100 million per year by Panacea Biotec. In Italy, production in 2021. In the Republic of Korea, production per year.
**** Ordered as of March 2021; discussions on more deliveries were ongoing.

Figures have been rounded.
The statistic has been compiled from press releases of the Russian Direct Investment Fund. The number of Sputnik V doses supplied to Belarus was obtained from the country's health ministry's Telegram channel, by Hungary from RBC., by Mexico, Bosnia & Herzegovina, and Honduras from Reuters, by Iran from Kommersant, by Argentina and Palestine from Interfax, by Algeria from Vesti.ru, by Paraguay from Gazeta.ru, by Slovakia and on production in Italy from ABC News, by North Macedonia from SeeNews, by Tunisia from France 24, by Mongolia from NewsMN, by Serbia from Tass.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Coronavirus (COVID-19) in Russia"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.